Evaluation of the safety profile and therapeutic efficacy of remdesivir in children with SARS-CoV-2 infection - a single-center, retrospective, cohort study.

Karolina Kuczborska Joanna WiśniowskaJoanna Friedman-GruszczyńskaPiotr Buda

Published in: European journal of pediatrics (2023)

• Remdesivir is a safe treatment for COVID-19 in the pediatric population. • In children with asymptomatic to moderate COVID-19 and risk factors for severe disease, remdesivir could be an effective drug to prevent disease progression. However, its efficacy in treating severe disease in children needs further exploration.

Keyphrases

coronavirus disease
young adults
sars cov
emergency department
drug induced
high intensity
combination therapy
smoking cessation